AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 40 filers reported holding AIM IMMUNOTECH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q2 2023 | $3,351 | – | 5,001 | +500000.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 1 | -99.1% | 0.00% | – |
| Q4 2022 | $34 | – | 113 | +11200.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2022 | $16,000 | +14.3% | 15,001 | -0.6% | 0.00% | – |
| Q4 2021 | $14,000 | -54.8% | 15,089 | -3.9% | 0.00% | – |
| Q3 2021 | $31,000 | -3.1% | 15,706 | +4.5% | 0.00% | – |
| Q2 2021 | $32,000 | -5.9% | 15,023 | -0.4% | 0.00% | – |
| Q1 2021 | $34,000 | +25.9% | 15,084 | +0.6% | 0.00% | – |
| Q4 2020 | $27,000 | -25.0% | 15,001 | -10.2% | 0.00% | – |
| Q3 2020 | $36,000 | -7.7% | 16,710 | +4.1% | 0.00% | – |
| Q2 2020 | $39,000 | -22.0% | 16,050 | -17.1% | 0.00% | – |
| Q1 2020 | $50,000 | +2400.0% | 19,367 | +497.9% | 0.00% | – |
| Q4 2019 | $2,000 | -75.0% | 3,239 | -68.3% | 0.00% | – |
| Q3 2019 | $8,000 | – | 10,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |